Media & Resources

Press Releases

Support from the U.S. Department of Defense Will Accelerate Progress on Vaccine Candidate for COVID-19, IAVI Says

October 27, 2020

NEW YORK — OCTOBER 27, 2020 — IAVI announced today the award of US$26.7M from the Defense Threat Reduction Agency (DTRA) of the U.S. Department of Defense (DoD) to support IAVI’s recombinant vesicular stomatitis virus (rVSV) vectored SARS-CoV-2 vaccine candidate. DTRA’s commitment will enable critical nonclinical development on the vaccine candidate that IAVI is developing…

Features

Progress Toward Global Access to Affordable Antibodies

October 23, 2020

There are more than 70 different mAbs in various stages of development for the treatment and prevention of COVID-19, including those discovered by a team of scientists including investigators from IAVI and Scripps Research.

Press Releases

IAVI, Merck KGaA, Darmstadt, Germany, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access

October 22, 2020

Partners aim to provide potent neutralizing antibodies for COVID-19 pandemic response.

In The News

Scientists build on HIV research in bid to stop snakebite deaths

Devex

October 21, 2020

Features

What are monoclonal antibodies, and can they treat COVID-19?

October 8, 2020

Monoclonal antibodies have changed the way we treat many diseases. They are a promising treatment for COVID-19, and IAVI is committed to developing SARS-CoV-2 antibodies that will be globally accessible.

Scientific Publications

Comparison of HIV Risk Behaviors Between Clinical Trials and Observational Cohorts in Uganda

Features

International Journal of Epidemiology publishes cohort profile of IAVI’s longitudinal HIV infection studies in Africa

September 28, 2020

Resulting knowledge and capacity continue to advance HIV vaccine research globally.

In The News

Merck, advancing single-dose and oral coronavirus vaccines, could still make Warp Speed: Bloomberg

Fierce Pharma

September 26, 2020

1…72 737475 76…235 of 235

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

Support from the U.S. Department of Defense Will Accelerate Progress on Vaccine Candidate for COVID-19, IAVI Says

Progress Toward Global Access to Affordable Antibodies

IAVI, Merck KGaA, Darmstadt, Germany, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access

Scientists build on HIV research in bid to stop snakebite deaths

What are monoclonal antibodies, and can they treat COVID-19?

Comparison of HIV Risk Behaviors Between Clinical Trials and Observational Cohorts in Uganda

International Journal of Epidemiology publishes cohort profile of IAVI’s longitudinal HIV infection studies in Africa

Merck, advancing single-dose and oral coronavirus vaccines, could still make Warp Speed: Bloomberg

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

Support from the U.S. Department of Defense Will Accelerate Progress on Vaccine Candidate for COVID-19, IAVI Says

Progress Toward Global Access to Affordable Antibodies

IAVI, Merck KGaA, Darmstadt, Germany, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access

Scientists build on HIV research in bid to stop snakebite deaths

What are monoclonal antibodies, and can they treat COVID-19?

Comparison of HIV Risk Behaviors Between Clinical Trials and Observational Cohorts in Uganda

International Journal of Epidemiology publishes cohort profile of IAVI’s longitudinal HIV infection studies in Africa

Merck, advancing single-dose and oral coronavirus vaccines, could still make Warp Speed: Bloomberg

Subscription Type